Corrigendum to “BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes” [Biochem. Pharmacol. 158 (2108) 232–242] (Biochemical Pharmacology (2018) 158 (232–242), (S0006295218304386), (10.1016/j.bcp.2018.10.017))

Shannon L. O'Brien, Elizabeth K.M. Johnstone, Dominic Devost, Jacinta Conroy, Melissa E. Reichelt, Brooke W. Purdue, Mohammed A. Ayoub, Tatsuo Kawai, Asuka Inoue, Satoru Eguchi, Terence E. Hébert, Kevin D.G. Pfleger, Walter G. Thomas

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors would like to point out that the wrong version of Fig. 7 has appeared in the published article. The figure currently appearing as Fig. 7 was, as part of the review process, incorporated into Fig. 6 and a new Fig. 7 was included. The submitted manuscript for review was correct, but unfortunately in the final uploads and proofing an error must have occurred and went undetected. The authors and journal apologise for this error. The correct Fig. 7 is below: [Figure presented]

Original languageEnglish
Article number114756
JournalBiochemical Pharmacology
Volume192
DOIs
Publication statusPublished - 2021 Oct

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Fingerprint

Dive into the research topics of 'Corrigendum to “BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes” [Biochem. Pharmacol. 158 (2108) 232–242] (Biochemical Pharmacology (2018) 158 (232–242), (S0006295218304386), (10.1016/j.bcp.2018.10.017))'. Together they form a unique fingerprint.

Cite this